Backed by top-tier investors from Silicon Valley and Europe, Eligo is an industry-leading biotechnology company, co-founded by scientists from MIT and the Rockefeller University – now operating in Paris, France. Eligo Bioscience has raised more than 55 million dollars from leading investors in Silicon Valley and in France to develop next-generation drugs that are based on the genetic engineering of bacteria and their viruses and aim to address unmet medical need in microbiome-associated diseases.
Our pioneering work in the field of synthetic biology has enabled Eligo to be elected as one of the 30 Most Innovative Companies by the World Economic Forum, to receive multiple prestigious international awards. We have also been featured in international media and scientific journals such as Nature, Nature Biotechnology, Science, The Economist, The BBC and The New York Times and nominated as one of the '30 Most Innovative Companies' by the World Economic Forum.
Eligonauts are driven, passionate, and motivated to impact the lives of patients by applying cutting-edge science to solve real unmet needs. We are at a very exciting point in time of the Eligo journey as we are embarking on the transition from a start-up deeply rooted in innovation to a clinical stage biotech with the objective to bring our lead program to the clinic within the next two years. We are therefore building a development team, in which the clinical development program lead will play a central role.
Eligo Bioscience has attracted highly-diverse top talent from all over the world, who are driven, passionate, and motivated to impact the lives of patients by applying cutting-edge science to save lives and treat chronic disease. Eligo embraces diversity, equal opportunity and inclusion and is committed to building diverse teams.
YOUR MISSION
At Eligo Bioscience, we are passionate about developing new drugs to address unmet medical needs !
Eligo is advancing its program in moderate to severe acne vulgaris into the clinic and expanding its pipeline into new disease areas. Our platform has also matured significantly and allows us to form and grow partnerships with pharmaceutical industries and key contract research organizations. We need to strictly monitor and adapt our financial plan to make the best use of our capital, while continuously improving financial and internal processes and strengthening a culture of business excellence to achieve our corporate KPIs.
This position is a 360° financial & corporate role with a great mix of operational responsibilities, internal process design and implementation and strategic support to Eligo leadership. You will be a key Business Partner to R&D and support function managers.
You will be responsible for financial planning, analysis and reporting. You will be instrumental in setting up financial tools and processes, adapted to current company needs and lead its proper implementation. You will bring a continuous improvement mindset to your missions and act as a subject matter expert for other departments.
RESPONSIBILITIES
Finance Management & Operations
Finance Management
Finance Operations
Corporate Support
Business Excellence
APPLICANT PROFILE
We are seeking a motivated candidate that can act as a vital thought partner to the Leadership team for all financial, corporate and business operations at Eligo.
QUALIFICATIONS